Privia Health Group’s (PRVA) “Buy” Rating Reiterated at Truist Financial

Truist Financial restated their buy rating on shares of Privia Health Group (NASDAQ:PRVA) in a research note released on Monday morning,Benzinga reports. Truist Financial currently has a $31.00 price target on the stock, up from their prior price target of $30.00.

A number of other research analysts also recently commented on PRVA. Evercore ISI upped their price objective on Privia Health Group from $28.00 to $30.00 and gave the stock an “outperform” rating in a research note on Friday, November 7th. Stephens restated an “overweight” rating and set a $32.00 price target on shares of Privia Health Group in a research report on Wednesday, September 24th. Zacks Research raised shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 19th. Barclays boosted their target price on shares of Privia Health Group from $21.00 to $22.00 and gave the company an “equal weight” rating in a research note on Thursday, October 9th. Finally, JMP Securities upped their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a “market outperform” rating in a research report on Friday, August 29th. Twelve research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, Privia Health Group presently has an average rating of “Moderate Buy” and a consensus target price of $29.92.

Privia Health Group Stock Down 0.4%

Shares of NASDAQ:PRVA opened at $24.22 on Monday. The company has a market cap of $2.98 billion, a PE ratio of 186.32, a P/E/G ratio of 3.45 and a beta of 0.83. Privia Health Group has a fifty-two week low of $18.77 and a fifty-two week high of $26.51. The firm has a 50-day simple moving average of $24.20 and a 200 day simple moving average of $22.78.

Privia Health Group (NASDAQ:PRVA) last issued its earnings results on Tuesday, June 7th. The company reported $0.10 EPS for the quarter. The company had revenue of $213.61 million during the quarter. Privia Health Group had a return on equity of 2.52% and a net margin of 0.89%. As a group, research analysts forecast that Privia Health Group will post 0.14 EPS for the current fiscal year.

Hedge Funds Weigh In On Privia Health Group

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in shares of Privia Health Group by 5.3% during the 3rd quarter. Vanguard Group Inc. now owns 12,098,933 shares of the company’s stock valued at $301,263,000 after purchasing an additional 607,447 shares during the period. State Street Corp boosted its stake in Privia Health Group by 1.5% during the second quarter. State Street Corp now owns 4,171,069 shares of the company’s stock valued at $95,935,000 after buying an additional 61,853 shares in the last quarter. Van Berkom & Associates Inc. grew its holdings in Privia Health Group by 30.1% during the third quarter. Van Berkom & Associates Inc. now owns 3,774,565 shares of the company’s stock worth $93,987,000 after acquiring an additional 873,344 shares during the period. Geode Capital Management LLC raised its position in Privia Health Group by 6.3% in the second quarter. Geode Capital Management LLC now owns 2,655,569 shares of the company’s stock worth $61,086,000 after acquiring an additional 158,521 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Privia Health Group by 180.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,633,040 shares of the company’s stock worth $59,112,000 after acquiring an additional 1,693,870 shares in the last quarter. 94.48% of the stock is owned by institutional investors.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.